<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <title>Funding</title>
 <p>A.S. was funded by grants from Knut and Alice Wallenberg Foundation, Wallenberg Centre for molecular and translational medicine, University of Gothenburg, Sweden; Swedish Cancer Society (19-0306); Swedish Research Council (2017-01392); Swedish Childhood Cancer Foundation (2017-0043 and 2020-0007); the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (716321). A.K.-L. was funded by the UiO: Life Science initiative through the convergence environment grant PerCaThe.</p>
</notes>
